Leaders of several Richmond-area biotechnology-related companies said Thursday that they foresee personalized medicine as a major force driving the industry’s growth, but access to capital for small firms with good ideas remains a challenge.
“Life sciences is really the big, huge growth industry,” said Mike Grisham, the chief executive officer of GPB Scientific, a Richmond-based company focused on using microchip technology in health and life-science research.
{iframe}http://medcitynews.com/2013/02/biotech-ceos-personalized-medicine-has-lots-of-promise-but-not-enough-funding/{/iframe}